Full Paper
mass spectra were obtained on a Bruker APEX IV instrument. Ele-
mental analyses were performed on a Carlo–Erba-1106 instrument.
The detailed spectroscopic and analytical data of all known and
new compounds is provided in the Supporting Information.
stirred at 808C until the organic layer became clear. The organic
layer was separated at room temperature, washed with water,
dried over Na2SO4, and concentrated under reduced pressure. The
residue was further purified by precipitation into methanol and/or
by silica column chromatography, giving the desired chiral dendrit-
ic Gn-BINAP ligands as an off-white powder.
General procedure for the synthesis of chiral dendritic di-
phosphine oxides Gn-BINAPO
G0-BINAP: Treatment of G0-BINAPO (1.08 g, 1 mmol) with trichloro-
silane (1 mL, 10 mmol) in toluene as the above procedure giving
G0-BINAP (0.77 g, 80%). 1H NMR (300 MHz, CDCl3): d=7.86–7.89
(m, 2H), 7.80–7.82 (m, 2H), 7.29–7.46 (m, 24H), 6.85–7.06 (m, 10H),
6.69–6.79 (m, 10H), 4.94–4.98 ppm (m, 8H); 13C NMR (75 MHz,
CDCl3): d=144.7, 144.4, 137.0, 137.0, 136.3, 136.0, 135.9, 135.7,
135.6, 134.5, 134.3, 134.2, 133.5, 133.4, 133.4, 133.2, 130.2, 129.3,
129.2, 129.1, 129.0, 128.9, 128.6, 128.6, 128.4, 128.1, 128.0, 127.7,
127.6, 127.5, 127.1, 127.0, 126.4, 125.8, 114.7, 114.7, 113.3, 70.6,
69.9, 69.8 ppm; 31P NMR (121 MHz, CDCl3): d=À20.0 ppm; MS
(MALDI-TOF): m/z calcd for C72H56O4P2: 1048.2 [M+H]+; found:
1045.5; elemental analysis calcd (%) for [C72H56O4P2]: C, 82.58; H,
5.39; found: C, 82.43; H, 5.68.
A mixture of OH-BINAPO, Gn-Br (6.0 equiv), K2CO3 (6.0 equiv), KI
(1.0 equiv), and a catalytic amount of 18-crown-6 in acetone was
stirred at 808C for 20 h. After being cooled to room temperature,
the organic solvent was evaporated under reduced pressure. The
residue was further purified by precipitation into methanol and/or
by silica column chromatography, giving the desired chiral dendrit-
ic Gn-BINAPO as an off-white powder.
G0-BINAPO: Treatment of OH-BINAPO (0.15 g, 0.2 mmol) and G0-Br
(0.21 g, 1.2 mmol) in acetone as the above procedure to give G0-
1
BINAPO (0.19 g, 70%). H NMR (300 MHz, CDCl3): d=7.75–7.78 (m,
4H), 7.51–7.58 (m, 4H), 7.30–7.40 (m, 28H), 6.75–6.83 (m, 12H),
5.03 (s, 4H), 4.96 ppm (s, 4H); 13C NMR (75 MHz, CDCl3): d=160.9,
136.5, 134.5, 134.3, 133.9, 133.7, 128.7, 128.6, 128.3, 128.1, 128.1,
127.7, 127.6, 127.5, 127.3, 127.1, 125.8, 114.4, 114.2, 69.9 ppm;
31P NMR (121 MHz, CDCl3): d=27.3 ppm. MS (MALDI-TOF): m/z
calcd (%) for C72H56O6P2: 1080.2 [M+H]+; found: 1079.2.
G1-BINAP: Treatment of G1-BINAPO (0.97 g, 0.5 mmol) with tri-
chlorosilane (0.5 mL, 5 mmol) in toluene as the above procedure
1
giving G1-BINAP (0.78 g, 82%). H NMR (300 MHz, CDCl3): d=7.84–
7.87 (m, 2H), 7.77–7.80 (m, 2H), 7.24–7.45 (m, 44H), 6.84–7.02 (m,
10H), 6.52–6.76(m, 22H), 4.86–5.02 ppm (m, 24H); 13C NMR
(75 MHz, CDCl3): d=160.2, 159.1, 158.6, 1445.0, 144.7, 144.3, 139.5,
136.9, 136.8, 136.5, 135.9, 135.8, 135.6, 134.5, 134.3, 134.2, 133.5,
133.4, 133.2, 130.3, 129.4, 129.4, 129.1, 129.1, 128.7, 128.6, 128.1,
128.1, 127.6, 127.5, 126.4, 125.8, 114.8, 106.4, 101.7, 101.6, 70.2,
70.1, 69.9, 69.8 ppm; 31P NMR (121 MHz, CDCl3): d=À19.2 ppm. MS
(MALDI-TOF): m/z calcd for C128H104O12P2: 1897.1 [M+H]+, found:
1896.1; elemental analysis calcd (%) for [C128H104O12P2]: C 81.08; H
5.53; found: C 80.53; H 5.66.
G1-BINAPO: Treatment of OH-BINAPO (0.15 g, 0.2 mmol) and G1-Br
(0.46 g, 1.2 mmol) in acetone as the above procedure giving G1-
1
BINAPO (0.33 g, 85%). H NMR (300 MHz, CDCl3): d=7.72–7.84 (m,
4H), 7.60–7.67 (m, 4H), 7.25–7.41 (m, 44H), 7.14–7.21 (m, 4H),
6.82–6.94 (m, 6H), 6.56–6.67 (m, 18H), 4.94–5.03 ppm (m, 24H);
13C NMR (75 MHz, CDCl3): d=161.1, 161.0, 160.3, 160.3, 139.1,
139.0, 136.9, 136.8, 134.6, 134.4, 134.1, 133.8, 128.7, 128.7, 128.2,
128.1, 127.7, 127.4, 114.6, 106.5, 101.8, 101.7, 70.3, 70.2, 69.9 ppm;
31P NMR (121 MHz, CDCl3): d=26.8 ppm. MS (MALDI-TOF): m/z
calcd for C128H104O14P2: 1929.1: [M+H]+; found:1928.0.
G2-BINAP: Treatment of G2-BINAPO (1.82 g, 0.5 mmol) with tri-
chlorosilane (0.5 mL, 5 mmol) in toluene as the above procedure
1
giving G2-BINAP (1.49 g, 83%). H NMR (300 MHz, CDCl3): d=7.83–
G2-BINAPO: Treatment of OH-BINAPO (0.15 g, 0.2 mmol) and G2-Br
(0.97 g, 1.2 mmol) in acetone as the above procedure giving G2-
7.86 (m, 2H), 7.76–7.79 (m, 2H), 7.26–7.39 (m, 84H), 6.89–7.02 (m,
10H), 6.48–6.87 (m, 46H), 4.84–5.02 ppm (m, 56H); 13C NMR
(75 MHz, CDCl3): d=160.8, 160.1, 160.0, 160.0, 159.0, 159.5, 144.9,
144.7, 144.4, 139.4, 139.2, 139.1, 138.9, 136.7, 136.7, 136.3, 135.8,
135.5, 134.2, 133.3, 133.1, 130.7, 130.6, 130.2, 129.0, 128.5, 127.9,
127.7, 127.5, 127.1, 126.4, 125.8, 114.7, 106.3, 101.5, 69.9 ppm;
31P NMR (121 MHz, CDCl3): d=À19.2 ppm; MS (MALDI-TOF): m/z
calcd for C240H200O28P2: 3595.1 [M+H]+; found: 3596.3; elemental
analysis calcd (%) for [C240H200O28P2]: C 80.20; H 5.61; found: C
80.15; H 5.67.
1
BINAPO (0.65 g, 90%). H NMR (300 MHz, CDCl3): d=7.62–7.68 (m,
4H), 7.43–7.50 (m, 4H), 7.07–7.34 (m, 90H), 6.64–6.70 (m, 10H),
6.43–6.55 (m, 36H), 4.75–4.86 ppm (m, 56H); 13C NMR (75 MHz,
CDCl3): d=160.9, 160.3, 160.2, 160.1, 160.0, 144.2, 143.0, 139.5,
139.3, 139.2, 139.1, 139.0, 136.9, 136.8, 134.6, 133.9, 133.8, 133.6,
130.1, 128.6, 128.6, 128.3, 128.1, 128.0, 127.8, 127.6, 127.2, 125.9,
114.5, 114.3, 106.5, 105.6, 101.7, 101.2, 70.1, 70.1, 70.0, 69.8 ppm;
31P NMR (121 MHz, CDCl3): d=28.3 ppm; MS (MALDI-TOF): m/z
calcd for C240H200O30P2: 3627.1 [M+H]+; found: 3626.1.
G3-BINAP: Treatment of G3-BINAPO (1.76 g, 0.25 mmol) with tri-
G3-BINAPO: Treatment of OH-BINAPO (0.08 g, 0.1 mmol) and G3-Br
(0.99 g, 0.6 mmol) in acetone as the above procedure giving G3-
BINAPO (0.60 g, 86%). H NMR (300 MHz, CDCl3): d=7.70–7.74 (m,
chlorosilane (0.25 mL, 2.5 mmol) in toluene as the above procedure
1
1
giving G3-BINAP (1.31 g, 75%). H NMR (300 MHz, CDCl3): d=7.80–
7.82 (m, 2H), 7.74–7.77 (m, 2H), 7.23–7.38 (m, 164H), 6.77–7.05 (m,
12H), 6.44–6.68(m, 92H), 4.75–5.01 ppm (m, 120H); 13C NMR
(75 MHz, CDCl3): d=160.2, 160.2, 159.2, 158.6, 158.5, 143.7, 139.31,
137.2, 136.9, 136.5, 136.2, 135.8, 134.3, 133.3, 130.4, 128.7, 128.3,
128.1, 127.6, 126.5, 125.9, 114.7, 106.5, 105.8, 101.7, 70.2, 70.1 ppm;
31P NMR (121 MHz, CDCl3): d=À20.1 ppm. MS (MALDI-TOF): m/z
calcd for C464H392O60P2: 7029.1 [M+K]+; found: 7025; elemental
analysis calcd (%) for [C464H392O60P2]: C 79.73; H 5.65; found: C
79.87; H 5.69.
4H), 7.42–7.56 (m, 4H), 7.15–7.37 (m, 170H), 6.46–6.86 (m, 94H),
4.65–5.00 ppm (m, 120H); 13C NMR (75 MHz, CDCl3): d=160.2,
160.1, 160.1, 160.0, 139.3, 139.2, 139.0, 136.8, 128.6, 128.6, 128.0,
128.0, 127.6, 114.4, 106.4, 101.6, 70.1, 70.0, 69.9 ppm; 31P NMR
(121 MHz, CDCl3): d=27.7 ppm. MS (MALDI-TOF): m/z calcd for
C464H392O62P2: 7023.0 [M+H]+; found: 7025.
General procedure for the synthesis of chiral dendritic di-
phosphine ligands Gn-BINAP
Trichlorosilane (10 equiv) was added carefully at 08C to a mixture
of Gn-BINAPO and N(n-Bu)3 (20 equiv) in degassed toluene under
nitrogen atmosphere. The mixture was then stirred at 1208C for
24 h. After being cooled to room temperature, degassed NaOH so-
lution (4m, 20 equiv) was added carefully. Then, the mixture was
General procedure for asymmetric hydrogenation and cata-
lyst recycling
In situ catalyst preparation: A 25 mL flask was charged with Gn-
BINAP (0.11 mmol), [RuI2(cymene)]2 (0.05 mmol) and degassed sol-
Chem. Eur. J. 2014, 20, 9969 – 9978
9976
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim